Michael Coleman - Dentsply Sirona Independent Director
| XRAY Stock | USD 30.86 0.49 1.61% |
Director
Mr. Michael J. Coleman is an Independent Director of the Company. he serves as director since 1993 since 1993.
| Age | 73 |
| Tenure | 31 years |
| Address | 13320-B Ballantyne Corporate Place, Charlotte, NC, United States, 28277-3607 |
| Phone | 844 848 0137 |
| Web | https://www.dentsplysirona.com |
Dentsply Sirona Management Efficiency
The company has return on total asset (ROA) of 0.0241 % which means that it generated a profit of $0.0241 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0372) %, meaning that it created substantial loss on money invested by shareholders. Dentsply Sirona's management efficiency ratios could be used to measure how well Dentsply Sirona manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.04 in 2024. Return On Capital Employed is likely to drop to 0.05 in 2024. At this time, Dentsply Sirona's Non Currrent Assets Other are fairly stable compared to the past year. Other Current Assets is likely to rise to about 271.9 M in 2024, whereas Total Assets are likely to drop slightly above 3.7 B in 2024.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Martin Harris | HealthStream | 61 | |
| Adrian Dillon | HealthEquity | 63 | |
| Brita Eilertsen | National Research Corp | 53 | |
| Ian Sacks | HealthEquity | 47 | |
| Harald Arnet | National Research Corp | N/A | |
| Linda Rebrovick | HealthStream | 62 | |
| Frank Medici | HealthEquity | 53 | |
| Frank Gordon | HealthStream | 55 | |
| P Shastri | National Research Corp | 65 | |
| Savita Acharya | National Research Corp | 41 | |
| JoAnn Martin | National Research Corp | 63 | |
| Michael Shmerling | HealthStream | 62 | |
| Thompson Dent | HealthStream | 68 | |
| John Nunnelly | National Research Corp | 65 | |
| Deborah Tate | HealthStream | 61 | |
| William Stead | HealthStream | 69 | |
| Jeffrey McLaren | HealthStream | 51 | |
| Dale Polley | HealthStream | 67 | |
| Manu Rana | HealthEquity | 45 | |
| Kjersti Kanne | National Research Corp | N/A | |
| Gayle Wellborn | HealthEquity | 56 | |
Management Performance
| Return On Equity | -0.0372 | ||||
| Return On Asset | 0.0241 |
Dentsply Sirona Leadership Team
Elected by the shareholders, the Dentsply Sirona's board of directors comprises two types of representatives: Dentsply Sirona inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Dentsply. The board's role is to monitor Dentsply Sirona's management team and ensure that shareholders' interests are well served. Dentsply Sirona's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dentsply Sirona's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Maureen MacInnis, Chief Human Resource Officer, Senior Vice President | ||
| Dan Workinger, Treasurer | ||
| Thomas Jetter, Lead Director, Independent Director | ||
| Paula Cholmondeley, Independent Director | ||
| Lisa Yankie, VP Officer | ||
| Francis Lunger, Independent Director | ||
| Andrew Robinson, VP Officer | ||
| Kevin Boyle, Senior Officer | ||
| Christopher Clark, Pres and CFO | ||
| Deborah Rasin, Vice President General Counsel, Secretary | ||
| Betsy Holden, Director | ||
| Donald Casey, CEO, Director | ||
| Derek Leckow, VP, Investor Relations | ||
| Andreas Frank, Executive Officer | ||
| Nicholas Alexos, Executive Vice President Chief Administrative Officer | ||
| Daniel Key, Senior Vice President Chief Supply Chain Officer | ||
| Justin McCarthy, General Counsel, Secretary | ||
| Albert Sterkenburg, Senior Vice President | ||
| Markus Boehringer, Senior Vice President - EMEA RCO | ||
| Erania Brackett, SVP Sustainability | ||
| Walter Petersohn, Senior Vice President Chief Commercial Officer | ||
| William Hecht, Lead Independent Director | ||
| Jonathan Friedman, Senior Vice President General Counsel, Secretary | ||
| Mark Thierer, Interim CEO | ||
| Cord Staehler, VP CTO | ||
| Bret Wise, Chairman, CEO and Chairman of Executive Committee | ||
| Glenn Coleman, Executive CFO | ||
| Henning Mueller, Group Vice President - Asia Pacific RCO | ||
| Ulrich Michel, CFO, Executive Vice President | ||
| Rainer Berthan, Executive Vice President Manufacturing and Supply Chain | ||
| Richard Wagner, Chief Officer | ||
| Cheree Johnson, Chief VP | ||
| Dane Baumgardner, AttorneyInFact | ||
| John Sweeney, vice president IR Contact Officer | ||
| Eric Bruno, Senior Vice President - North America Regional Commercial Organization | ||
| Jorge Gomez, CFO, Executive Vice President | ||
| Andrea Daley, Vice Relations | ||
| Robert Size, Sr. VP | ||
| Harry Kraemer, Director | ||
| Andrea Frohning, Senior Officer | ||
| Michael Coleman, Independent Director | ||
| David Beecken, Director | ||
| Leslie Varon, Director | ||
| Eric Brandt, Independent Director | ||
| Robert Johnson, Senior Officer | ||
| William Newell, Senior Vice President Chief Segment Officer | ||
| Willie Deese, Independent Director | ||
| Simon Campion, President CEO | ||
| Keith Ebling, Executive Vice President General Counsel, Secretary | ||
| John Miles, Independent Director | ||
| Richard Rosenzweig, General Development | ||
| Michael Alfano, Independent Director | ||
| James Mosch, COO and Executive VP | ||
| Emily Miner, Senior Officer | ||
| John Miclot, Independent Director | ||
| Arthur Kowaloff, Director | ||
| Jeffrey Slovin, CEO, Director |
Dentsply Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Dentsply Sirona a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0372 | ||||
| Return On Asset | 0.0241 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 8.25 B | ||||
| Shares Outstanding | 207.63 M | ||||
| Shares Owned By Insiders | 0.36 % | ||||
| Shares Owned By Institutions | 99.64 % | ||||
| Number Of Shares Shorted | 10.46 M | ||||
| Price To Earning | 19.16 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Dentsply Sirona offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dentsply Sirona's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dentsply Sirona Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dentsply Sirona Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Dentsply Sirona. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Dentsply Stock please use our How to Invest in Dentsply Sirona guide.Note that the Dentsply Sirona information on this page should be used as a complementary analysis to other Dentsply Sirona's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Dentsply Stock analysis
When running Dentsply Sirona's price analysis, check to measure Dentsply Sirona's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dentsply Sirona is operating at the current time. Most of Dentsply Sirona's value examination focuses on studying past and present price action to predict the probability of Dentsply Sirona's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dentsply Sirona's price. Additionally, you may evaluate how the addition of Dentsply Sirona to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
Is Dentsply Sirona's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dentsply Sirona. If investors know Dentsply will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dentsply Sirona listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.178 | Dividend Share 0.56 | Earnings Share (0.62) | Revenue Per Share 18.703 | Quarterly Revenue Growth 0.03 |
The market value of Dentsply Sirona is measured differently than its book value, which is the value of Dentsply that is recorded on the company's balance sheet. Investors also form their own opinion of Dentsply Sirona's value that differs from its market value or its book value, called intrinsic value, which is Dentsply Sirona's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dentsply Sirona's market value can be influenced by many factors that don't directly affect Dentsply Sirona's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dentsply Sirona's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dentsply Sirona is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dentsply Sirona's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.